Re: [MOL] multi myeloma/Reply- Thalidomide [01054] Medicine On Line


[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

Re: [MOL] multi myeloma/Reply- Thalidomide



Online there is way to contact the thalidamide company directly and inquire
about orphan drug use. It is very very expensive and is not being
manufactured in large quantities, but the company can help with costs.

----- Original Message -----
From: Lillian <firefly@islc.net>
To: <mol-cancer@lists.meds.com>
Sent: Tuesday, August 24, 1999 10:54 PM
Subject: Re: [MOL] multi myeloma/Reply- Thalidomide


> Here are some sites for you to explore regarding Thalidomide, your friend,
> lillian
>
>
> 1. FDA Panel Okays Thalidomide With Strict Caveats
> A Food and Drug Administration expert panel recommended that thalidomide
be
> approved for use in patients with erythema nodosum leprosum--with
> stringent...
> URL: www.medscape.com/IMNG/SkinAllergyNews/19...2810.01.01.html
> Last modified 29-May-99 - page size 12K - in English [ Translate ]
>
> 2. New Uses For Thalidomide Yielding Valuable Lessons
> New Uses For Thalidomide Yielding Valuable Lessons. Author: Kathryn S.
Brown
> Date: February 3, 1997. Sidebar: Researchers Explore Thalidomide's...
> URL: 165.123.33.33/yr1997/feb/brown_p1_970203.html
> Last modified 30-May-99 - page size 18K - in English [ Translate ]
>
> 1. FDA Panel Okays Thalidomide With Strict Caveats
> A Food and Drug Administration expert panel recommended that thalidomide
be
> approved for use in patients with erythema nodosum leprosum--with
> stringent...
> URL: www.medscape.com/IMNG/SkinAllergyNews/19...2810.01.01.html
> Last modified 29-May-99 - page size 12K - in English [ Translate ]
> 2. New Uses For Thalidomide Yielding Valuable Lessons
> New Uses For Thalidomide Yielding Valuable Lessons. Author: Kathryn S.
Brown
> Date: February 3, 1997. Sidebar: Researchers Explore Thalidomide's...
> URL: 165.123.33.33/yr1997/feb/brown_p1_970203.html
> Last modified 30-May-99 - page size 18K - in English [ Translate ]
> HOME PAGE. THALIDOMIDE. Thalidomide has anti-angiogenic properties (which
> resulted in disastrous birth defects during the 60's). Initial clinical
> trials...
> URL: www.slip.net/~mcdavis/thalidom.html
> Last modified 8-Jan-99 - page size 8K - in English (Win-1252)
[ Translate ]
>
> 6. Thalidomide: A new lease of life
> Thalidomide has recently become a drug of renewed clinical interest,
> especially in human immunodeficiency virus (HIV) disease. This follows
> thirty years...
> URL: www.dashnet.com/acrpi/article9.htm
> Last modified 26-Jul-98 - page size 9K - in English [ Translate ]
>
> 7. Thalidomide Shows Promising Results in Patients with Multiple Myeloma;
> Initial
> Monday September 28, 8:02 am Eastern Time Press Release SOURCE: University
> of Arkansas for Medical Sciences Thalidomide Shows Promising Results in...
> URL: www.celgene.com/uarkrelease.htm
> Last modified 28-Sep-98 - page size 3K - in English [ Translate ]
>
> ------------------------------------------------------------------------
> This is an automatically-generated notice.  If you'd like to be removed
> from the mailing list, please visit the Medicine-On-Line Discussion Forum
> at <http://www.meds.com/con_faq.html>, or send an email message to:
> majordomo@lists.meds.com
> with the subject line blank and the body of the message containing the
line:
> unsubscribe mol-cancer your-email-address
> where the phrase your-email-address is replaced with your actual email
> address.
> ------------------------------------------------------------------------
>

------------------------------------------------------------------------
This is an automatically-generated notice.  If you'd like to be removed
from the mailing list, please visit the Medicine-On-Line Discussion Forum
at <http://www.meds.com/con_faq.html>, or send an email message to:
majordomo@lists.meds.com
with the subject line blank and the body of the message containing the line:
unsubscribe mol-cancer your-email-address
where the phrase your-email-address is replaced with your actual email
address.
------------------------------------------------------------------------